$2.58
-0.100 (-3.73%)
At Close: Jun 03, 2026
3 Penny Stocks Under $3 To Watch In March
02:17pm, Friday, 17'th Mar 2023
Penny stocks to watch right now. The post 3 Penny Stocks Under $3 To Watch In March appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Nautilus Biotechnology, Inc. (NAUT) Q4 2022 Earnings Call Transcript
03:09pm, Saturday, 25'th Feb 2023
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM ET Company Participants Sujal Patel - Co-Founder and CEO Anna Mowry - CFO Parag Mallick - Co-Foun
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
08:00am, Thursday, 26'th Jan 2023
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will rep
Nautilus Biotechnology, Inc. (NAUT) Q3 2022 Earnings Call Transcript
02:35pm, Tuesday, 01'st Nov 2022
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q3 2022 Earnings Conference Call November 1, 2022 8:30 AM ET Company Participants Sujal Patel - Co-Founder and CEO Parag Mallick - Co-Founder and Chief Scie
Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference
08:00am, Tuesday, 30'th Aug 2022
SEATTLE, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome
Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q2 2022 Results - Earnings Call Transcript
12:02pm, Tuesday, 02'nd Aug 2022
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ET Company Participants Sujal Patel - Founder and Chief Executive Officer Anna Mowry - Chief Financi
Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q1 2022 Results - Earnings Call Transcript
12:21pm, Tuesday, 03'rd May 2022
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q1 2022 Earnings Conference Call May 3, 2022 8:30 AM ET Company Participants Sujal Patel - Co-Founder & CEO Anna Mowry - CFO Parag Mallick - Co-Founder & Ch
Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022
08:00am, Thursday, 07'th Apr 2022
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteom
Nautilus Biotechnology to Present at EuPA and AACR Meetings
08:00am, Monday, 04'th Apr 2022
• Co-founder and Chief Scientist Parag Mallick, Ph.D., to present lecture at Annual Congress of the European Proteomics Association (EuPA) • Associate Director Greg Kapp, Ph.D., to present poste
Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q4 2021 Results - Earnings Call Transcript
10:42am, Saturday, 26'th Feb 2022
Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q4 2021 Results - Earnings Call Transcript
Jim Cramer considers the investment cases for Nautilus Biotechnology and Cyxtera Technologies
08:11pm, Friday, 21'st Jan 2022
On Friday's episode of "Mad Money," host Jim Cramer reviewed the investment cases for Nautilus Biotechnology and Cyxtera Technologies, two companies that viewers had previously called about in search
Nautilus Biotechnology: Recent Selloff Provides A Fantastic Entry Point
02:34pm, Friday, 07'th Jan 2022
Nautilus operates in the field of Proteomics, a $25 billion market, growing at 12% per year.
Penny Stocks To Buy This Week: 4 To Watch Right Now
02:54pm, Thursday, 02'nd Dec 2021
Are these on your list of penny stocks to buy this week? The post Penny Stocks To Buy This Week: 4 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c
Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q3 2021 Results - Earnings Call Transcript
02:48pm, Tuesday, 02'nd Nov 2021
Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q3 2021 Results - Earnings Call Transcript
Nautilus Biotechnology to Announce Third Quarter of Fiscal Year 2021 Financial Results on November 2, 2021
08:00am, Monday, 11'th Oct 2021
SEATTLE, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome
Sign In
Buy NAUT